210 related articles for article (PubMed ID: 30020484)
1. Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals.
Agyemang E; Magaret AS; Selke S; Johnston C; Corey L; Wald A
J Infect Dis; 2018 Oct; 218(11):1691-1699. PubMed ID: 30020484
[TBL] [Abstract][Full Text] [Related]
2. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
[TBL] [Abstract][Full Text] [Related]
3. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
4. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
5. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
[TBL] [Abstract][Full Text] [Related]
6. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
Leone P; Warren T; Hamed K; Fife K; Wald A
Sex Transm Dis; 2007 Nov; 34(11):900-7. PubMed ID: 17538513
[TBL] [Abstract][Full Text] [Related]
7. Helicase-primase inhibitor pritelivir for HSV-2 infection.
Wald A; Corey L; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Kriesel J; Fife K; Galitz L; Stoelben S; Huang ML; Selke S; Stobernack HP; Ruebsamen-Schaeff H; Birkmann A
N Engl J Med; 2014 Jan; 370(3):201-10. PubMed ID: 24428466
[TBL] [Abstract][Full Text] [Related]
8. Once daily valacyclovir for reducing viral shedding in subjects newly diagnosed with genital herpes.
Martens MG; Fife KH; Leone PA; Dix LP; Brennan CA
Infect Dis Obstet Gynecol; 2009; 2009():105376. PubMed ID: 19680456
[TBL] [Abstract][Full Text] [Related]
9. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
[TBL] [Abstract][Full Text] [Related]
10. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection.
Tronstein E; Johnston C; Huang ML; Selke S; Magaret A; Warren T; Corey L; Wald A
JAMA; 2011 Apr; 305(14):1441-9. PubMed ID: 21486977
[TBL] [Abstract][Full Text] [Related]
11. Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial.
Bender Ignacio RA; Perti T; Magaret AS; Rajagopal S; Stevens CE; Huang ML; Selke S; Johnston C; Marrazzo J; Wald A
J Infect Dis; 2015 Dec; 212(12):1949-56. PubMed ID: 26044291
[TBL] [Abstract][Full Text] [Related]
12. Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition.
Ramchandani M; Selke S; Magaret A; Barnum G; Huang MW; Corey L; Wald A
Sex Transm Infect; 2018 Dec; 94(8):568-570. PubMed ID: 29175899
[TBL] [Abstract][Full Text] [Related]
13. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.
Wald A; Corey L; Cone R; Hobson A; Davis G; Zeh J
J Clin Invest; 1997 Mar; 99(5):1092-7. PubMed ID: 9062368
[TBL] [Abstract][Full Text] [Related]
14. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
[TBL] [Abstract][Full Text] [Related]
15. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
[TBL] [Abstract][Full Text] [Related]
17. The effects of daily distress and personality on genital HSV shedding and lesions in a randomized, double-blind, placebo-controlled, crossover trial of acyclovir in HSV-2 seropositive women.
Strachan E; Saracino M; Selke S; Magaret A; Buchwald D; Wald A
Brain Behav Immun; 2011 Oct; 25(7):1475-81. PubMed ID: 21693182
[TBL] [Abstract][Full Text] [Related]
18. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.
Wald A; Zeh J; Selke S; Warren T; Ryncarz AJ; Ashley R; Krieger JN; Corey L
N Engl J Med; 2000 Mar; 342(12):844-50. PubMed ID: 10727588
[TBL] [Abstract][Full Text] [Related]
19. Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.
Phipps W; Nakku-Joloba E; Krantz EM; Selke S; Huang ML; Kambugu F; Orem J; Casper C; Corey L; Wald A
J Infect Dis; 2016 Feb; 213(3):439-47. PubMed ID: 26486633
[TBL] [Abstract][Full Text] [Related]
20. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
Johnston C; Saracino M; Kuntz S; Magaret A; Selke S; Huang ML; Schiffer JT; Koelle DM; Corey L; Wald A
Lancet; 2012 Feb; 379(9816):641-7. PubMed ID: 22225814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
